Andere talen Alpha Cognition Inc.

Aandelen

ACOG

CA02074J2048

Beurs gesloten - Canadian Securities Exchange Andere beurzen 21:51:32 30-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,76 ^CAD	+4,83%		+5,56%	+15,15%

15/05	Alpha Cognition Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
04/04	Alpha Cognition's nettoverlies over het vierde kwartaal neemt iets toe ten opzichte van het voorgaande jaar	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	04/04
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
Alpha Cognition to Present at the Life Science Investor Forum March 7th	01/03
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease	22/02
Alpha Cognition Inc. Files Composition-Of-M Matter Patent	22/02
Alpha Cognition Provides Business Update	12/02
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment	19/01
Alpha Cognition Inc. announced that it has received $8.45 million in funding	19/01
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering	22/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's disease	08/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease	07/12
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease	07/12
Alpha Cognition Reports Amended Terms of Private Placement, Continuation of the Offering	05/12
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering	05/12
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering	08/11
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering	16-10-23
Canadian Investment Regulatory Organization Trading Halt - ACOG.WT	02-10-23
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease	27-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Alpha Cognition Inc.

Aandelen

ACOG

CA02074J2048

Andere talen

Filters